Wird geladen...
Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease of unknown origin that has variable clinical course and can affect nearly any organ. It has a chronic course in about 25% of patients. Corticosteroids (CS) are the cornerstone of therapy but their long-term use is associated with cumulative toxicity...
Gespeichert in:
| Veröffentlicht in: | Front Med (Lausanne) |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732552/ https://ncbi.nlm.nih.gov/pubmed/33330556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.594133 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|